Edap Tms (EDAP) Set to Announce Quarterly Earnings on Thursday

Edap Tms (NASDAQ:EDAP) is set to announce its earnings results before the market opens on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.04). Edap Tms had a negative net margin of 31.68% and a negative return on equity of 36.41%. The firm had revenue of $16.97 million for the quarter, compared to the consensus estimate of $17.16 million. On average, analysts expect Edap Tms to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Edap Tms Trading Up 3.3 %

Shares of EDAP stock traded up $0.09 during mid-day trading on Tuesday, hitting $2.78. The company’s stock had a trading volume of 2,802 shares, compared to its average volume of 45,931. The company has a market cap of $103.15 million, a PE ratio of -4.64 and a beta of 0.38. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.80 and a current ratio of 2.45. The company’s fifty day simple moving average is $2.91 and its 200-day simple moving average is $4.60. Edap Tms has a 52 week low of $2.27 and a 52 week high of $8.50.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on EDAP shares. HC Wainwright reiterated a “buy” rating and issued a $19.00 target price on shares of Edap Tms in a report on Thursday, August 29th. StockNews.com raised shares of Edap Tms from a “sell” rating to a “hold” rating in a research note on Wednesday, September 25th.

About Edap Tms

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.